[德国心力衰竭:流行病学和最近的发展]
Josefine Rudolph1, Stephan von Haehling1,2
1Klinik für Kardiologie und Pneumologie, Universitätsmedizin Göttingen, Göttingen.
Deutsche medizinische Wochenschrift (1946)
|October 28, 2025
概括
在德国,心力衰竭的治疗涉及四个关键药物类别,但这些治疗可以导致电解质失衡,如低或高血和缺铁. 警监测这些并发症对于患者的安全至关重要.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学 是一个学科.
- 内部医学 内部医学
背景情况:
- 降低射出分数 (HFrEF) 的心力衰竭是德国住院的主要原因,造成了重大负担.
- 自2021年以来,目前的基于证据的HFrEF管理依赖于四个药理学支柱:β-阻断剂,萨库比特里尔/瓦尔萨坦 (或ACE抑制剂),矿物质皮质醇受体对抗剂和SGLT-2抑制剂.
- 这些必不可少的疗法虽然改善了结果,但与不良影响有关,特别是电解质干扰和缺铁.
研究的目的:
- 审查德国和欧洲最近有关心力衰竭的流行病学数据.
- 概述目前针对HFrEF的指导方针导向的医学疗法.
- 突出关键的治疗相关并发症需要临床管理.
主要方法:
- 对心力衰竭的最新流行病学数据的文献综述.
- 目前针对HFrEF的指导方针导向疗法的摘要.
- 识别和讨论关键的与治疗有关的并发症.
主要成果:
- 心力衰竭仍然是住院的主要原因,需要谨慎管理.
- 治疗HFrEF的四个支柱可以导致低卡或高卡血,增加心律失常的风险.
- 铁缺乏症在HFrEF患者中很常见,静脉注射铁制剂正在进行校正测试.
结论:
- 有效的HFrEF管理需要平衡治疗效益与潜在的不良影响.
- 警监测电解质障碍 (低/高卡血症) 和缺铁是非常重要的.
- 临床医生必须准备好预测和管理这些与治疗相关的并发症.
相关概念视频
Pathophysiology of Heart Failure
5.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
5.1K
Heart Failure I: Introduction
2.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2.0K
Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Heart Failure III: Clinical Manifestations
1.4K
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.4K
Heart Failure IV: Classification and Diagnostic Evaluation
1.2K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.2K
Heart Failure V: Medical Management
641
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641


